Combination of celecoxib with percutaneous radiotherapy in patients with localised prostate cancer – a phase I study
Ute Ganswindt(Innsbruck Medical University), Claus Belka(LMU Klinikum)
Cited by 29
Related Papers
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement
|Radiotherapy and Oncology|2020|227
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus
|Radiotherapy and Oncology|2022|98